HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arzu Didem Yalcin Selected Research

anti-IgE antibodies

8/2020A case of asthma with Behcet's disease: successful treatment with omalizumab and its effects on recurrent aphthous lesions.
9/2016Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone.
6/2016Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels.
1/2014Serum soluble CD200 level was higher in patients with bullous pemphigoid during the active phase of the disease than for healthy individuals.
1/2014Omalizumab (anti-IgE) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 month follow-up.
1/2014Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200.
9/2013Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels.
1/2013Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arzu Didem Yalcin Research Topics

Disease

14Asthma (Bronchial Asthma)
08/2020 - 01/2012
6Neoplasms (Cancer)
04/2020 - 01/2012
5Hypersensitivity (Allergy)
09/2014 - 01/2012
4Inflammation (Inflammations)
06/2016 - 12/2012
3Dyspnea (Shortness of Breath)
08/2020 - 01/2013
3Anaphylaxis (Anaphylactic Shock)
01/2015 - 01/2012
3Colonic Neoplasms (Colon Cancer)
10/2013 - 01/2012
2Cough
08/2020 - 01/2012
2Diabetes Mellitus
08/2020 - 01/2014
2Blister (Bulla)
09/2016 - 01/2014
2Drug-Related Side Effects and Adverse Reactions
09/2016 - 01/2013
2Stevens-Johnson Syndrome (Lyell's Syndrome)
09/2016 - 01/2013
2Chronic Urticaria
09/2014 - 03/2014
2Bullous Pemphigoid (Pemphigoid)
01/2014 - 01/2014
2Hepatitis
03/2012 - 01/2012
1Cytokine Release Syndrome
02/2021
1COVID-19
02/2021
1Multiple Organ Failure (MODS)
02/2021
1Septic Shock (Toxic Shock Syndrome)
02/2021
1Severe Acute Respiratory Syndrome
02/2021
1Rheumatoid Arthritis
08/2020
1Spondylarthritis (Spinal Arthritis)
08/2020
1Behcet Syndrome (Behcet's Syndrome)
08/2020
1Inborn Genetic Diseases (Disease, Hereditary)
08/2020
1Pneumonia (Pneumonitis)
09/2016
1Breast Neoplasms (Breast Cancer)
08/2016
1Carcinogenesis
08/2016
1Migraine Disorders (Migraine)
06/2016
1Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome
06/2016
1Respiratory Sounds (Crackle)
06/2016
1Netherton Syndrome
01/2016
1Parasitic Diseases (Parasitic Disease)
01/2015
1Pain (Aches)
01/2015
1Carcinoid Tumor (Carcinoid)
01/2015
1Urticaria (Hives)
01/2015
1Pruritus (Itching)
01/2015
1Food Hypersensitivity (Food Allergy)
09/2014
1Atopic Dermatitis (Atopic Eczema)
09/2014
1Latex Hypersensitivity (Latex Allergy)
09/2014
1Thrombosis (Thrombus)
03/2014
1Chronic Hepatitis C
01/2014

Drug/Important Bio-Agent (IBA)

16Omalizumab (Xolair)FDA Link
08/2020 - 01/2012
8anti-IgE antibodiesIBA
08/2020 - 01/2013
6Monoclonal AntibodiesIBA
02/2021 - 01/2012
6CytokinesIBA
02/2021 - 09/2013
5Immunoglobulin E (IgE)IBA
01/2014 - 01/2012
3Interleukin-4 (Interleukin 4)IBA
02/2021 - 01/2016
3Interleukin-8 (Interleukin 8)IBA
02/2021 - 01/2012
3Prednisolone (Predate)FDA LinkGeneric
09/2016 - 01/2013
3fibrin fragment D (D-dimer)IBA
09/2014 - 09/2013
3C-Reactive ProteinIBA
09/2014 - 12/2012
3Bevacizumab (Avastin)FDA Link
10/2013 - 01/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2013 - 01/2012
2Interleukin-2 (IL2)IBA
02/2021 - 06/2016
2Interleukin-17 (Interleukin 17)IBA
02/2021 - 01/2016
2Interleukin-5 (Interleukin 5)IBA
02/2021 - 01/2016
2Biological ProductsIBA
02/2021 - 01/2020
2SteroidsIBA
08/2020 - 01/2014
2Immunoglobulins (Immunoglobulin)IBA
09/2016 - 01/2016
2Peptides (Polypeptides)IBA
09/2016 - 09/2014
2hydroxide ionIBA
09/2014 - 09/2013
2AntioxidantsIBA
09/2014 - 01/2012
2Protein CIBA
03/2014 - 09/2013
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2014 - 01/2012
2TNF-Related Apoptosis-Inducing LigandIBA
10/2013 - 03/2012
2Penicillins (Penicillin)FDA Link
09/2013 - 01/2012
2AllergensIBA
08/2013 - 02/2013
2Rheumatoid FactorIBA
03/2012 - 01/2012
2Antinuclear AntibodiesIBA
03/2012 - 01/2012
1remdesivirIBA
02/2021
1favipiravirIBA
02/2021
1Interleukin-33IBA
02/2021
1InterleukinsIBA
02/2021
1Interleukin-6 (Interleukin 6)IBA
02/2021
1Interleukin-7 (Interleukin 7)IBA
02/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2021
1Interleukin-10 (Interleukin 10)IBA
02/2021
1Interleukin-12 (IL 12)IBA
02/2021
1Interleukin-13IBA
02/2021
1Trastuzumab (Herceptin)FDA Link
04/2020
1Levofloxacin (Levaquin)FDA Link
09/2016
1AntigensIBA
08/2016
1Biomarkers (Surrogate Marker)IBA
08/2016
1ChemokinesIBA
08/2016
1LigandsIBA
08/2016
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2016
1Bee Venoms (Bee Venom)IBA
09/2014
1Glycoproteins (Glycoprotein)IBA
09/2014
1HomocysteineIBA
09/2014
1CopperIBA
09/2014
1Proteins (Proteins, Gene)FDA Link
09/2014
1RNA (Ribonucleic Acid)IBA
09/2014
1Vitamin DFDA LinkGeneric
09/2014
1AlbuminsIBA
09/2014
1Antithrombin IIIIBA
03/2014
1AnticoagulantsIBA
03/2014
1Protein SIBA
03/2014
1Fibrin Fibrinogen Degradation ProductsIBA
03/2014

Therapy/Procedure

11Therapeutics
08/2020 - 01/2013
1Length of Stay
08/2020